Clinical Trial Update: Mesenchymal Stromal Cells in Living Donor Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mesenchymal stromal cell therapy to improve outcomes in living donor kidney transplantation; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Mesenchymal stromal cells (MSC) therapy (mesenchymal stromal cells)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Renal Transplantation, Mesenchymal Stem Cells | Phase 2 | Status: ACTIVE_NOT_RECRUITING